Natasha M. Savage

Augusta University — United States

Medicine · Health Sciences

23h-index2.1kcitations141works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Eosinophilic Disorders and Syndromes(25), Fibroblast Growth Factor Research(19), Cancer Immunotherapy and Biomarkers(17), Acute Myeloid Leukemia Research(16), Immune Cell Function and Interaction(14)

Publications141 total

Lipid nanoparticle Fas gene therapy suppresses autoimmune lymphoproliferative syndrome in mice
Blood Immunology & Cellular Therapy·2025Open Access
Chronic Cavitary Pulmonary Histoplasmosis–Novel Concepts Regarding Pathogenesis
Journal of Fungi·2025· 1 citedOpen Access
S2502 Development of IgG4-Related Disease and Autoimmune Pancreatitis-Like Changes on Cross-Sectional Imaging After GLP-1 Agonist
The American Journal of Gastroenterology·2024· 1 cited
Sideroblastic Anemia
2024
A Push to Consider Mantle Cell Lymphoma in Adults with Leukemia/Lymphoma with Blastoid Morphology
Hematology Reports·2023Open Access
Significant Variability in the Identification and Reporting of Band Neutrophils by Participants Enrolled in the College of American Pathologists Proficiency Testing Program: Time for a Change
Archives of Pathology & Laboratory Medicine·2023· 8 citedOpen Access
Optical Genome Mapping: Integrating Structural Variations for Precise Homologous Recombination Deficiency Score Calculation
Genes·2023· 3 citedOpen Access
Clinical Utility of Optical Genome Mapping and 523-Gene Next Generation Sequencing Panel for Comprehensive Evaluation of Myeloid Cancers
Cancers·2023· 10 citedOpen Access
Abstract LB036: IRF8 regulates tumor cell sensitivity to intrinsic ferroptosis by repressing p53
Cancer Research·2023
Figure S2 from Loss of Fas Expression and Function Is Coupled with Colon Cancer Resistance to Immune Checkpoint Inhibitor Immunotherapy
2023Open Access
Figure S4 from Loss of Fas Expression and Function Is Coupled with Colon Cancer Resistance to Immune Checkpoint Inhibitor Immunotherapy
2023Open Access
Supplementary Figure Legend from Loss of Fas Expression and Function Is Coupled with Colon Cancer Resistance to Immune Checkpoint Inhibitor Immunotherapy
2023Open Access
Figure S1 from Loss of Fas Expression and Function Is Coupled with Colon Cancer Resistance to Immune Checkpoint Inhibitor Immunotherapy
2023Open Access
Figure S5 from Loss of Fas Expression and Function Is Coupled with Colon Cancer Resistance to Immune Checkpoint Inhibitor Immunotherapy
2023Open Access
Figure S3 from Loss of Fas Expression and Function Is Coupled with Colon Cancer Resistance to Immune Checkpoint Inhibitor Immunotherapy
2023Open Access
Data from Loss of Fas Expression and Function Is Coupled with Colon Cancer Resistance to Immune Checkpoint Inhibitor Immunotherapy
2023Open Access
Supplementary Figure Legend from Loss of Fas Expression and Function Is Coupled with Colon Cancer Resistance to Immune Checkpoint Inhibitor Immunotherapy
2023Open Access
Data from Loss of Fas Expression and Function Is Coupled with Colon Cancer Resistance to Immune Checkpoint Inhibitor Immunotherapy
2023Open Access
Figure S1 from Loss of Fas Expression and Function Is Coupled with Colon Cancer Resistance to Immune Checkpoint Inhibitor Immunotherapy
2023Open Access
Figure S5 from Loss of Fas Expression and Function Is Coupled with Colon Cancer Resistance to Immune Checkpoint Inhibitor Immunotherapy
2023Open Access
page 1 of 8Next →

Frequent Co-authors

Kebin Liu(12), Chunwan Lu(9), Huidong Shi(6), John D. Klement(6), Dafeng Yang(6), Vamsi Kota(6), Gurmukh Singh(5), Priscilla S. Redd(4), Alyssa D. Merting(4), Tracy I. George(4), Ashis K. Mondal(4), Ravindra Kolhe(4), Roni J. Bollag(4), Nicholas H. Oberlies(3), Cedric J. Pearce(3), Nagendra Singh(3), Dakota B. Poschel(3), Celalettin Üstün(3), Anand Jillella(3), Jason Gotlib(3)